Equities Research Analysts’ downgrades for Monday, November 25th:
Arthur J. Gallagher & Co. (NYSE:AJG) was downgraded by analysts at The Goldman Sachs Group, Inc. from a buy rating to a neutral rating. They currently have $313.00 target price on the stock.
Banco Bradesco (NYSE:BBD) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating.
Baidu (NASDAQ:BIDU) was downgraded by analysts at China Renaissance from a buy rating to a hold rating. China Renaissance currently has $86.00 target price on the stock.
Perspective Therapeutics (NYSE:CATX) was downgraded by analysts at Bank of America Co. from a buy rating to a neutral rating. They currently have $5.00 price target on the stock, down from their previous price target of $24.00.
Community Health Systems (NYSE:CYH) was downgraded by analysts at Wells Fargo & Company from an equal weight rating to an underweight rating. The firm currently has $2.50 price target on the stock, down from their previous price target of $5.00.
Despegar.com (NYSE:DESP) was downgraded by analysts at TD Cowen from a buy rating to a sell rating. They currently have $14.00 price target on the stock, up from their previous price target of $12.00.
Editas Medicine (NASDAQ:EDIT) was downgraded by analysts at Bank of America Co. from a buy rating to an underperform rating. They currently have $1.00 price target on the stock, down from their previous price target of $13.00.
Expensify (NASDAQ:EXFY) was downgraded by analysts at JMP Securities from an outperform rating to a market perform rating.
Eagle Materials (NYSE:EXP) was downgraded by analysts at Loop Capital from a buy rating to a hold rating. Loop Capital currently has $315.00 target price on the stock.
Extreme Networks (NASDAQ:EXTR) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
Five Below (NASDAQ:FIVE) was downgraded by analysts at Telsey Advisory Group from an outperform rating to a market perform rating. The firm currently has $95.00 price target on the stock, down from their previous price target of $102.00.
Barrick Gold (NYSE:GOLD) (TSE:ABX) was downgraded by analysts at CIBC from a sector outperform rating to a neutral rating.
HCA Healthcare (NYSE:HCA) was downgraded by analysts at Wells Fargo & Company from an equal weight rating to an underweight rating. They currently have $320.00 price target on the stock, down from their previous price target of $400.00.
M&T Bank (NYSE:MTB) was downgraded by analysts at Citigroup Inc. from a buy rating to a neutral rating. They currently have $230.00 price target on the stock, up from their previous price target of $220.00.
Mainz Biomed (NASDAQ:MYNZ) was downgraded by analysts at HC Wainwright from a buy rating to a neutral rating.
NIO (NYSE:NIO) was downgraded by analysts at The Goldman Sachs Group, Inc. from a neutral rating to a sell rating. They currently have $3.90 target price on the stock, down from their previous target price of $4.80.
Newmark Group (NASDAQ:NMRK) was downgraded by analysts at Wolfe Research from an outperform rating to a peer perform rating.
Northwest Pipe (NASDAQ:NWPX) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
Red Rock Resorts (NASDAQ:RRR) was downgraded by analysts at Mizuho from an outperform rating to a neutral rating. They currently have $44.00 price target on the stock, down from their previous price target of $57.00.
Smith Douglas Homes (NYSE:SDHC) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. They currently have $36.00 price target on the stock, down from their previous price target of $41.00.
Select Medical (NYSE:SEM) was downgraded by analysts at Benchmark Co. from a buy rating to a hold rating.
Block (NYSE:SQ) was downgraded by analysts at BMO Capital Markets from an outperform rating to a market perform rating. The firm currently has $100.00 target price on the stock, up from their previous target price of $94.00.
Tenet Healthcare (NYSE:THC) was downgraded by analysts at Wells Fargo & Company from an overweight rating to an equal weight rating. Wells Fargo & Company currently has $150.00 target price on the stock, down from their previous target price of $205.00.
Receive News & Ratings for Arthur J Gallagher & Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arthur J Gallagher & Co and related companies with MarketBeat.com's FREE daily email newsletter.